Amy Brennan, an experienced biopharma leader who has been with the company for 20 years, has been appointed as Site Head at Sanofi Waterford.
Amy succeeds Dr Johannes Schweppenhäuser who has moved to a new role within Sanofi after leading the Waterford site from May 2019.
Amy Brennan, Site Head, Waterford said "It is a huge honour to be appointed as the sixth Site Head at Waterford since the site was established in 2001. I look forward to leading an amazing team through the next phase of the site’s journey and to enabling them to achieve their full potential at Sanofi. Our team of committed and skilled people serve patients right around the world who rely on treatments from Waterford. This is a privilege that we never lose sight of.”
Growth from within
Originally from Kilkenny, Amy joined the Waterford site team in 2002 having just graduated from the then Waterford Institute of Technology. Over the intervening 20 years, she has held roles of increasing responsibility across the site and beyond. In the same period, the Waterford headcount has increased five-fold to 800 as it has grown and diversified to serve additional patients.
At Sanofi Waterford, Amy was a member of the site leadership team for four years from 2016. During this time, she had spells leading a key operational area and quality. In 2020, she moved internally within Sanofi.
SETU & DCU Graduate
Amy holds a Bachelor’s Degree in Manufacturing Technology and a Masters in Science from South East Technological University (SETU) and an MBA from Dublin City University (DCU).
Sanofi is an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. The team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. The company provides potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the centre of our ambitions.